Quanex Building Products Corporation Common Stock (NX)
StalwartFairStock Score: 56/100 — STEADY
Key Financials
| Current Price | $16.61 |
| Market Cap | $942M |
| P/E Ratio | -3.19 |
| ROE | -29.75% |
| Dividend Yield | 2.08% |
| Sector | Industrials |
Strengths
- Generates $86 million in annual free cash flow (9.1% yield on market cap)
Concerns
- Currently unprofitable—sustained losses could lead to dilutive capital raises or balance sheet deterioration
- Weak Piotroski F-Score of 1/9 suggests deteriorating financial quality across multiple dimensions
- Altman Z-Score of 1.0 places it in the financial distress zone—elevated bankruptcy risk
AI Analysis
Quanex Building Products Corporation Common Stock is a micro-cap industrials company valued at $942 million. Revenue stands at $1.8 billion, though the company is currently unprofitable. From a quality standpoint, Quanex shows weak Piotroski F-Score of 1/9 signaling deteriorating fundamentals and distressed Altman Z-Score of 1.0 warrants caution. Growth dynamics show revenue growing at 2.3% and profit growth of 72.7%. The 1.7% dividend yield adds an income component for patient holders. Our composite FairStock Score of 56/100 reflects mixed fundamentals overall. Without profitability, this remains speculative—suitable only for those with high risk tolerance and a long time horizon.
Bull Case
Improving fundamentals and sector tailwinds could drive meaningful earnings growth, compressing the effective multiple for patient investors. With $86 million in annual free cash flow (9.1% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.
Bear Case
Without a clear path to profitability, continued cash burn forces either dilutive equity raises or debt accumulation that destroys shareholder value. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer